Cargando…
Metopimazine is primarily metabolized by a liver amidase in humans
Metopimazine (MPZ) is a peripherally restricted, dopamine D2 receptor antagonist used for four decades to treat acute nausea and vomiting. MPZ is currently under clinical investigation for the treatment of gastroparesis (GP). MPZ undergoes high first‐pass metabolism that produces metopimazine acid (...
Autores principales: | Busby, Robert W., Cai, Xiaokun, Yang, Sihyung, Ramos, Luis, Venkatarangan, Lata, Shen, Helen, Wax, Stephen, Sadeque, Abu J. M., De Colle, Cyril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929364/ https://www.ncbi.nlm.nih.gov/pubmed/34918875 http://dx.doi.org/10.1002/prp2.903 |
Ejemplares similares
-
Pharmacokinetic study of metopimazine by oral route in children
por: Mallet, Eric, et al.
Publicado: (2015) -
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy
por: Sigsgaard, T, et al.
Publicado: (1999) -
An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell division
por: Senzani, Sibusiso, et al.
Publicado: (2017) -
Functional Characterization of Corynebacterium glutamicum Mycothiol S-Conjugate Amidase
por: Si, Meiru, et al.
Publicado: (2014) -
An Amidase Contributes to Full Virulence of Sclerotinia sclerotiorum
por: Li, Wei, et al.
Publicado: (2022)